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Summary
A 77-year-old woman without traditional risk factors for 
coronary artery disease (CAD) underwent coronary CT-
angiography for evaluation of palpitations after negative 
Holter monitoring and non-diagnostic ECG exercise 
stress test. Coronary artery calcium score was reported 
zero; 1 day later, she was admitted with anterior-
wall ST elevation myocardial infarction. Acute left 
anterior descending artery thrombus was treated with 
mechanical thrombectomy and Percutaneous Coronary 
Intervention (PCI). Interestingly, the coronary arteries 
were angiographically normal. During hospitalisation, 
paroxysmal atrial fibrillation was noted followed by 
initiation of anticoagulation. Echocardiogram did not 
show thrombus or atrial shunt. Cardioversion with 
Sotalol was successful. Myocardial infraction was 
most likely cardioembolic secondary to paroxysmal 
atrial fibrillation—consistent with longstanding 
history of palpitations. Accounting for 3% of acute 
coronary syndromes, coronary embolism is treated 
with therapeutic anticoagulation for at least 3 months 
irrespective of cause and carries a higher risk of adverse 
cardiovascular events.
BaCkground
Estimated 3% of acute coronary syndromes (ACS) 
are caused by coronary embolism (CE). In patients 
with ACS without significant underlying coronary 
artery disease (CAD), embolic aetiology should 
be considered. Diagnosis of CE may be difficult 
in patients with paroxysmal atrial fibrillation, as 
the rhythm may be normal at presentation. Iden-
tification of CE subgroup of patients with ACS 
is important because of increased risk for major 
adverse cardiac outcomes and importance of 
systemic anticoagulation in prevention of future 
embolic events.
CaSe preSenTaTion
A 77-year-old non-smoker woman presented with 
sudden onset substernal chest pain radiating to the 
left arm. ECG showed anterior wall ST-elevation 
myocardial infarction (STEMI). Haemodynamically 
stable, emergent cardiac catheterisation revealed a 
100% acute occlusion of the proximal left ante-
rior descending artery (LAD, figure 1A). Left main, 
circumflex and right coronary arteries were normal 
(0% stenosis reported); no circumflex-LAD or right 
coronary artery (RCA)–LAD collaterals were noted. 
Mechanical thrombectomy was performed followed 
by the placement of two stents in the proximal LAD. 
Guideline-directed post-STEMI medical therapy 
was initiated: aspirin, clopidogrel, beta-adrenergic 
antagonist, statin and ACE inhibitor.
Few weeks prior to her presentation with STEMI, 
the patient was seen in outpatient cardiology office 
for daily symptoms of palpitations and progressive 
exertional dyspnoea. According to the patient, her 
heartbeat has ‘felt irregular’ for several years. No 
prior history of hypertension, diabetes mellitus, 
dyslipidemia, atrial fibrillation or cardiovascular 
disease was reported. At the office visit, 12-lead 
ECG was sinus rhythm with premature ventric-
ular complexes (PVCs). 24 hours Holter monitor 
was notable for sinus rhythm with premature atrial 
contractions (2.1% of beats) and PVCs (1.2% of 
beats). The patient then underwent an ECG stress 
test with non-diagnostic ST and T wave changes.
Given the non-diagnostic stress test and atyp-
ical symptoms, 1 day prior to her presentation with 
STEMI, a coronary CT angiogram was performed 
which revealed a coronary artery calcium (CAC) 
score of zero and no CAD whatsoever.
inveSTigaTionS
1. Troponin 10.38 ng/mL (reference: <0.05 ng/
mL).
2. Fasting lipid panel—low density lipoprotein 
(LDL) 118 mg/dL; total cholesterol 202 mg/dL 
(reference: <200 mg/dL); triglycerides 100 mg/
dL (reference: <150 mg/dL); high density lipo-
protein (HDL) 64 mg/dL (reference: >35 mg/
dL).
3. Fasting serum glucose 100 mg/dL.
4. Transthoracic ECHO: Left ventricular ejection 
fraction 35%–39% with segmental wall motion 
abnormalities. Normal-sized left and right atria. 
No mitral stenosis or aortic valve abnormality. 
No patent foramen ovale.
5. Echocardiographic evaluation was negative for 
an inter-atrial communication or cardiac mass-
es.
6. No inter-atrial communication was detected by 
the right heart catheterisation.
differenTial diagnoSiS
Given the normal coronary arteries on computed 
tomography angiography (CTA) followed by LAD 
occlusion with high clot burden, investigation for 
non-atherosclerotic embolic causes ensued. There 
was no history of hypercoagulable state, and the 
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patient denied miscarriages or arterial/venous thrombosis. Like-
wise, no history of atrial septal defect, endocarditis or recent/
remote cardiac intervention was reported. Transthoracic echo-
cardiogram was unrevealing for an intracardiac shunt, thrombus 
or mass. Despite extensive discussion and explanation of the 
diagnostic and therapeutic benefit, the patient declined tran-
soesophageal echocardiography. Extended ambulatory rhythm 
monitoring was planned but on the second day of hospitalisa-
tion, paroxysmal atrial fibrillation was recorded on telemetry 
(figure 2).
TreaTmenT
Systemic oral anticoagulation was initiated (Apixaban 5 mg two 
times per day) followed by successful pharmacologic cardiover-
sion with Sotalol. Dual antiplatelet (aspirin and clopidogrel) and 
post-STEMI guideline-directed medical therapy were continued, 
including high intensity statin and ACE inhibitor, but metoprolol 
was replaced by Sotalol.
ouTCome and follow-up
The patient was discharged after unremarkable 72 hours moni-
toring for QTc prolongation post-initiation of Sotalol. Triple 
therapy with aspirin, clopidogrel and apixaban was continued 
at discharge with the intent to discontinue aspirin after 6 weeks 
to minimise bleeding risk. No chest pain, exertional dyspnoea 
or heart failure symptoms were reported at 1 week follow-up. 
The patient’s ECG showed normal sinus rhythm with resolving 
ST-elevations. Ejection fraction was preserved on repeat trans-
thoracic ECHO. Monthly appointments are scheduled for close 
monitoring and observation for bleeding on long-term anticoag-
ulation (CHA2DS2VASc score=5) and clopidogrel.
diSCuSSion 
Causes of CE are broadly divided into three categories: direct, 
paradoxical and iatrogenic.1 In causes classified as direct, the 
embolus originates from a thrombus in the left atrium and 
ventricle, mitral and aortic valves, pulmonary veins or proximal 
coronary artery—with paroxysmal or persistent atrial fibrillation 
being the most common cause (73%).2 Other direct aetiologies 
of CE due to the left-sided thrombus include endocarditis and 
post-myocardial infraction left ventricular thrombus.1 Para-
doxical CE may also be secondary to venous thrombi entering 
the systemic circulation through an atrial septal defect, patent 
foramen ovale or pulmonary arteriovenous malformation.1
When compared with the cerebral and systemic circulation, 
the coronary arterial vasculature is relatively protected from 
emboli because of difference in calibre of the aorta and main 
coronary arteries, the acute angle at which the coronaries origi-
nate from the aorta, and the fast flow across the coronary ostia.1 
Consequently, CE is a rare cause of ACS overall (2.9%) and 
STEMI (4.3%).2 3
Clinical presentation of acute myocardial infarction due to CE 
is indistinguishable from atherosclerotic myocardial infarction.1 
Consequently, the initial ACS management is the same, regard-
less of the aetiology. However, recognition of CE, in addition to 
specific medical management, is important because of the need 
for closer monitoring in this subpopulation and increased risk of 
cardiac death as compared with the patients with atherosclerotic 
myocardial infarction.3Patients with CE myocardial infarction 
suffer from significantly increased 5-year risk of adverse cardiac 
and cerebrovascular events, which may be as high as 27%.2 Age 
greater than 60 years, female gender, reduced left ventricular 
ejection fraction and atrial fibrillation are independent risk 
factors for major adverse cardiovascular events in patients with 
non-atherosclerotic myocardial infarction,4 emphasising the 
importance of recognising CE and associated prognostic factors.
CE diagnosis may be suspected on retrospective evaluation 
of coronary angiogram when the occlusive thrombus burden is 
disproportionate to the degree of atherosclerosis, no or minimal 
atherosclerosis in other coronary territories, or there is evidence 
of concomitant systemic embolisation in other arterial beds, for 
example, cerebral, mesenteric, retinal or in extremities.2Com-
pared with those patients with atherosclerotic CAD, patients 
with CE are less likely to have traditional risk factors—hyper-
tension, dyslipidemia, smoking and diabetes.5 However, it may 
reflect a selection bias, as more thorough search for embolic 
source is performed in patients with ACS without significant 
risk factors for systemic atherosclerosis. Anticoagulation is the 
treatment of choice for all patients with CE, and thrombophilia 
testing is not routinely indicated.1 However, decision for testing 
needs to be individualised, for instance to determine duration of 
treatment in patients with unexplained venous thromboembo-
lism and/or who are at higher risk for bleeding.
Major CE diagnostic criteria (suggested by Shibata et al2) 
include (1) angiographic findings of coronary vessel occlusion 
without atherosclerosis; (2) concomitant involvement of multiple 
coronary territories and/or distal systemic embolism; (3) histo-
logic evidence of venous thrombus and (4) echocardiographic/
CT/MRI evidence of intracardiac thrombus. Minor criteria 
include (1) <25% stenosis of non-culprit coronary vessels, (2) 
known atrial fibrillation and (3) risk factor for embolism (eg, 
patent foramen ovale, atrial septal defect, dilated cardiomyop-
athy, prosthetic valve, etc.). Our patient met one major criterion 
(angiographic evidence of large thrombus without significant 
underlying atherosclerosis, figure 1B) and two minor criteria 
figure 1 (A) Left anterior oblique (LAO) caudal view of proximal 
left anterior descending artery (LAD) occlusion (arrow). (B) Right 
anterior oblique (RAO) cranial view of non-diseased LAD (arrow) post-
thrombectomy and Percutaneous Coronary Intervention  (PCI).
figure 2 Atrial fibrillation on 12-lead ECG.
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(atrial fibrillation and <25% stenosis in non-culprit vessels) 
qualifying as definite CE.2
There was no significant coronary atherosclerosis by inva-
sive angiogram in the acute setting. Moreover, a coronary 
CTA performed just 1 day prior to the STEMI presentation 
did not reveal any evidence for atherosclerotic disease what-
soever. False-negative results of CT coronary angiography do 
occur with reported negative predictive values of 80%–90%.6 
However, these false-negative results typically occur in patients 
with atherosclerotic disease in whom a particular intracoronary 
lesion is ‘undercalled’ by the reader. In the case presented, the 
CAC score of 0 and finding of no non-calcified plaque make a 
false-negative CT result very unlikely. Finally, in some patients, 
myocardial infarction may cause atrial fibrillation.7 But our 
patient had longstanding history of palpitations which, in retro-
spect, were probably due to undiagnosed paroxysmal atrial 
fibrillation. In suspected embolic infarct, post-thrombectomy 
intravascular ultrasound would have been useful in ruling out 
dissection or eroded plaque and, in the presence of normal vessel 
morphology, would have confirmed the diagnosis of embolism.8 
In confirmed embolic myocardial infarction, it would have obvi-
ated the need for triple antithrombotic therapy (dual antiplatelet 
and anticoagulation).
The chronology of events in the presented case serves as a 
reminder of the clinical characteristics associated with CE, its 
diagnostic evaluation and treatment to reduce risk of recurrence. 
Although there are no formal guidelines for management of CE, 
workup should include extended cardiac rhythm monitoring for 
detection of paroxysmal or persistent atrial fibrillation (the most 
common cause of CE) and transoesophageal echocardiography 
for detection of left atrial thrombus and right-to-left shunt. In 
retrospect, delayed enhancement cardiac MRI could have been 
offered as an alternative to transoesophageal echocardiography 
for left atrial thrombus detection.9
The recommended treatment for CE is systemic anticoagula-
tion. The duration of anticoagulation in CE due to paradoxical 
right-to-left embolism depends on the underlying thrombosis 
aetiology and risk-profile, with treatment duration of 3 months 
if risk factors are transient, or longer if persistent.1 As in the 
presented patient, if atrial fibrillation is detected (CHA2DS-
2VASc assigned to a minimum of two in men and three in 
women with CE), long-term anticoagulation is indicated. Addi-
tional complexity of patient care and increased bleeding risk 
due to dual antiplatelet therapy and systemic anticoagulation 
should be considered as well. In patients with increased bleeding 
risk on dual antiplatelet therapy who require systemic antico-
agulation, aspirin may be stopped 4 weeks after the acute event 
with acceptable long-term outcomes.7 Thrombectomy and long-
term anticoagulation are adequate therapy for CE secondary to 
atrial fibrillation. The role of left atrial appendage closure for 
prevention of the CE events in patients with atrial fibrillation is 
currently unclear. This case highlights the benefit of evaluating 
suspected CE with intravascular ultrasound or optical coherence 
tomography post-thrombectomy to avoid unnecessary percuta-
neous coronary intervention and bleeding risk associated with 
triple antithrombotic therapy.
learning points
 ► Coronary embolism (CE) is an under-recognised cause of 
acute coronary syndrome associated with worse cardiac and 
cerebrovascular outcomes compared with atherosclerotic 
heart disease.
 ► Atrial fibrillation is the most common cause of CE. Long-
term rhythm monitoring for detection of atrial fibrillation is 
indicated.
 ► Thrombophilia testing is not routinely indicated in CE except 
for unexplained venous thrombosis.
 ► Increased bleeding risk due to dual antiplatelet therapy and 
systemic anticoagulation should be considered. Evaluation 
of suspected CE with post-thrombectomy intravascular 
ultrasound may prevent unnecessary percutaneous coronary 
intervention and bleeding risk associated with triple 
antithrombotic therapy.
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